Simple Summary Circulating tumor cell (CTC) detection is a non-invasive and easy way to
collect and separate single cells to use as tumor biomarkers. In this article, we show the …

Background Colorectal cancer is among the most prominent malignant tumors endangering
human health, with affected populations exhibiting an increasingly younger trend. The …

Despite the introduction of new molecular classifications, advanced colorectal cancer (CRC)
is treated with chemotherapy supplemented with anti-EGFR and anti-VEGF targeted therapy …

Background Molecular aberrations in KRAS, NRAS, BRAF, and PIK3CA have been well-
described in advanced colorectal cancer. The incidences of other mutations are less known …

Gastrointestinal stromal tumors (GISTs) are characterized by mutations in exons 9, 11, 13,
and 17 of KIT or exons 12, 14, and 18 of PDGFRA gene. However, approximately 10 to 15 …

Purpose Although the mutation status of KRAS is highly concordant in primary and
metastatic lesions, it has not been generalized to other major pathway genes. Materials and …

Colorectal cancer (CRC) is the second most common cancer in men and the third most
common cancer in women. Although long‐term survival has improved over the past 30 …

Corchorus olitorius L. is a highly consumed plant in Cyprus and other Eastern
Mediterranean countries and known as a medicinal food in many cultures. The aim of the …

Background Several recent studies have reported that patients with metastatic colorectal
cancer (CRC) whose primary tumor is located in left side of the colon have more favorable …

Abstract Aberrant PD‐L1 (CD274) expression has been described in different types of
tumour and linked to tumour aggressiveness and a poor prognosis. In primary colorectal …